{"created":"2021-03-01T06:20:50.870767+00:00","id":16269,"links":{},"metadata":{"_buckets":{"deposit":"9d71f017-360a-4026-a25a-c2c43c570230"},"_deposit":{"id":"16269","owners":[],"pid":{"revision_id":0,"type":"depid","value":"16269"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00016269","sets":["453:456","471:537:538:1101"]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1998-12","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"12","bibliographicPageEnd":"776","bibliographicPageStart":"773","bibliographicVolumeNumber":"112","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The treatment of hypercholesterolemia was progressed rapidly with the appearance of new anti-hyperlipidemia agents, simvastain and plavastatin. These agents certainly decreased serum cholesterol level and ishemic events derived from atheloscrelosis of coronary artery. This results has been proved by several clinical mass studies. However, familial hypercholesterolemia(FH) is registive to statin agents and its pognosis is poor because of ishemic disease. Low density lipoprotein (LDL) apheresis is recognized as an effective treatment for lowering serum cholesterole level of FH patients. We studied our own FH treated with LDL apheresis and discussed the clinical effectiveness of LDL apheresis.","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"103734","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Nishi, Shinichi"}]},{"nameIdentifiers":[{"nameIdentifier":"103735","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Ei, Kyouko"}]},{"nameIdentifiers":[{"nameIdentifier":"103736","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Oda, Mizue"}]},{"nameIdentifiers":[{"nameIdentifier":"103737","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Arakawa, Masaaki"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"西, 慎一"}],"nameIdentifiers":[{"nameIdentifier":"103730","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"惠, 京仔"}],"nameIdentifiers":[{"nameIdentifier":"103731","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"小田, 瑞恵"}],"nameIdentifiers":[{"nameIdentifier":"103732","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"荒川, 正昭"}],"nameIdentifiers":[{"nameIdentifier":"103733","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-07"}],"displaytype":"detail","filename":"112(12)_773-776.pdf","filesize":[{"value":"743.3 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"112(12)_773-776.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/16269/files/112(12)_773-776.pdf"},"version_id":"010a8e75-4858-4e88-8cbf-802a9b2b405d"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"LDL","subitem_subject_scheme":"Other"},{"subitem_subject":"Familial hypercholesterolemia","subitem_subject_scheme":"Other"},{"subitem_subject":"Ahperesis","subitem_subject_scheme":"Other"},{"subitem_subject":"Athelosclerosis","subitem_subject_scheme":"Other"},{"subitem_subject":"Coronary artery disease","subitem_subject_scheme":"Other"},{"subitem_subject":"家族性高コレステロール血症","subitem_subject_scheme":"Other"},{"subitem_subject":"吸着療法","subitem_subject_scheme":"Other"},{"subitem_subject":"動脈硬化","subitem_subject_scheme":"Other"},{"subitem_subject":"冠動脈疾患","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"6)難治性高コレステロール血症におけるLDL吸着療法（シンポジウム 高脂血症, 動脈硬化をめぐって, 第540回新潟医学会）","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"6)難治性高コレステロール血症におけるLDL吸着療法（シンポジウム 高脂血症, 動脈硬化をめぐって, 第540回新潟医学会）"},{"subitem_title":"6)難治性高コレステロール血症におけるLDL吸着療法（シンポジウム 高脂血症, 動脈硬化をめぐって, 第540回新潟医学会）","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","1101"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-02-14"},"publish_date":"2017-02-14","publish_status":"0","recid":"16269","relation_version_is_last":true,"title":["6)難治性高コレステロール血症におけるLDL吸着療法（シンポジウム 高脂血症, 動脈硬化をめぐって, 第540回新潟医学会）"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:47:45.091791+00:00"}